Ghost Tree Capital, LLC quarter change: USA Stocks, Added
In share positions in stocks (listed in the US), from the quarter ended 2024-06-30 to 2024-09-30, Ghost Tree Capital, LLC opened 8 positions, added to 15, reduced 20, sold out of 14 and left 2 unchanged. The largest increase in value was JANX (+$6,537,200); the largest decrease was BHVN (-$17,007,900).
- JANX: Country of operation United States; Class COM; Shares 2024-06-30 50,000; Shares 2024-09-30 190,000.
- SRPT: Country of operation United States; Class COM; Shares 2024-06-30 55,000; Shares 2024-09-30 120,000.
- TARS: Country of operation United States; Class COM; Shares 2024-06-30 235,000; Shares 2024-09-30 350,000.
- VKTX: Country of operation United States; Class COM; Shares 2024-06-30 95,000; Shares 2024-09-30 140,000.
Two Form 13F-HR filings compared (SEC CIK 1595851): 2024-06-30 (filed 2024-08-14) and 2024-09-30 (filed 2024-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
| Stock | Country of operation | Class | Shares 2024-06-30 | Shares 2024-09-30 | Share change | Value 2024-06-30 | Value 2024-09-30 | Value change |
|---|
JANX
JANUX THERAPEUTICS INC | United States | COM | 50,000 | 190,000 | +140,000 | $2,094,500 | $8,631,700 | +$6,537,200 |
|---|
SRPT
SAREPTA THERAPEUTICS INC | United States | COM | 55,000 | 120,000 | +65,000 | $8,690,000 | $14,986,800 | +$6,296,800 |
|---|
TARS
TARSUS PHARMACEUTICALS INC | United States | COM | 235,000 | 350,000 | +115,000 | $6,387,300 | $11,511,500 | +$5,124,200 |
|---|
VKTX
VIKING THERAPEUTICS INC | United States | COM | 95,000 | 140,000 | +45,000 | $5,035,950 | $8,863,400 | +$3,827,450 |
|---|
ANNX
ANNEXON INC | United States | COM | 310,000 | 650,000 | +340,000 | $1,519,000 | $3,848,000 | +$2,329,000 |
|---|
ARVN
ARVINAS INC | United States | COM | 75,000 | 145,000 | +70,000 | $1,996,500 | $3,571,350 | +$1,574,850 |
|---|
TSHA
TAYSHA GENE THERAPIES INC | United States | COM SHS | 1,250,000 | 2,150,000 | +900,000 | $2,800,000 | $4,321,500 | +$1,521,500 |
|---|
SNDX
SYNDAX PHARMACEUTICALS INC | United States | COM | 350,000 | 450,000 | +100,000 | $7,185,500 | $8,662,500 | +$1,477,000 |
|---|
TNYA
TENAYA THERAPEUTICS INC | United States | COM | 1,350,000 | 1,500,000 | +150,000 | $4,185,000 | $2,895,000 | -$1,290,000 |
|---|
INSM
INSMED INC | United States | COM PAR $.01 | 65,000 | 75,000 | +10,000 | $4,355,000 | $5,475,000 | +$1,120,000 |
|---|
RZLT
REZOLUTE INC | United States | COM NEW | 1,421,501 | 1,474,995 | +53,494 | $6,112,454 | $7,153,726 | +$1,041,272 |
|---|
BBIO
BRIDGEBIO PHARMA INC | United States | COM | 140,000 | 175,000 | +35,000 | $3,546,200 | $4,455,500 | +$909,300 |
|---|
RGNX
REGENXBIO INC | United States | COM | 170,000 | 265,000 | +95,000 | $1,989,000 | $2,779,850 | +$790,850 |
|---|
KRRO
KORRO BIO INC | United States | COM | 100,000 | 110,000 | +10,000 | $3,387,000 | $3,676,200 | +$289,200 |
|---|
NUVB
NUVATION BIO INC | United States | COM CL A | 1,150,000 | 1,350,000 | +200,000 | $3,358,000 | $3,091,500 | -$266,500 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |